{"url_path":"/sec/crbp/8-k/2026-07-06/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1595097/0001193125-26-295622-index.html","accession_number":"0001193125-26-295622","cik":"0001595097","ticker":"CRBP","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1595097/0001193125-26-295622-index.html","primary_entity_key":"0001595097","primary_entity_name":"Corbus Pharmaceuticals Holdings, Inc."},"word_count":168,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits:\n\nExhibit No.\n\nDescription\n\n10.1\n\n \n\n[Employment Agreement, dated July 2, 2026, between Corbus Pharmaceuticals Holdings, Inc. and Leonardo Viana Nicacio, MD.](crbp-ex10_1.htm)\n\n10.2\n\n \n\n[Form of Inducement Stock Option Award Agreement (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 17, 2026).](https://www.sec.gov/Archives/edgar/data/1595097/000119312526274226/crbp-ex4_2.htm)\n\n10.3\n\n \n\n[Form of Inducement Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 17, 2026).](https://www.sec.gov/Archives/edgar/data/1595097/000119312526274226/crbp-ex4_3.htm)\n\n99.1\n\n \n\n[Press Release issued by Corbus Pharmaceuticals Holdings, Inc. dated July 6, 2026.](crbp-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nCorbus Pharmaceuticals Holdings, Inc.\n\nDate:\n\nJuly 6, 2026\n\nBy:\n\n/s/ Yuval Cohen\n\nName: Yuval Cohen\nTitle: Chief Executive Officer"}